Pascale A. Cohen

Faculty Of Medicine Lyon Est
Lyon, 69372, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4-Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis.

Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4-Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis.

Journal: Cancers

Published: December 30, 2025

Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma.

Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma.

Journal: Cancers

Published: February 16, 2024

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.

The Intricate Interplay between the ZNF217 Oncogene and Epigenetic Processes Shapes Tumor Progression.

Journal: Cancers

Published: October 27, 2022

Non-coding RNA in rhabdomyosarcoma progression and metastasis.

Non-coding RNA in rhabdomyosarcoma progression and metastasis.

Journal: Frontiers in oncology

Published: June 16, 2022

Editorial: New Technologies in Cancer Diagnostics and Therapeutics.

Editorial: New Technologies in Cancer Diagnostics and Therapeutics.

Journal: Frontiers in pharmacology

Published: August 18, 2021

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer.

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer.

Journal: Frontiers in oncology

Published: January 29, 2021

Editorial: Impact of Cancer Plasticity on Drug Resistance and Treatment in Solid Tumors.

Editorial: Impact of Cancer Plasticity on Drug Resistance and Treatment in Solid Tumors.

Journal: Frontiers in oncology

Published: August 20, 2020

Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay.

Long-Term Exposure of Early-Transformed Human Mammary Cells to Low Doses of Benzo[a]pyrene and/or Bisphenol A Enhances Their Cancerous Phenotype via an AhR/GPR30 Interplay.

Journal: Frontiers in oncology

Published: November 29, 2019

Editorial: Novel Targets and Biomarkers in Solid Tumors.

Editorial: Novel Targets and Biomarkers in Solid Tumors.

Journal: Frontiers in pharmacology

Published: June 22, 2019

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer.

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer.

Journal: International journal of molecular sciences

Published: March 25, 2019

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers.

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers.

Journal: Frontiers in pharmacology

Published: November 19, 2018

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice.

The Bone Morphogenetic Protein Signaling Inhibitor LDN-193189 Enhances Metastasis Development in Mice.

Journal: Frontiers in pharmacology

Published: November 18, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026